All News

Weight-loss surgery has no impact on obese men's poor sperm quality, despite improvements in their hormonal profile and sexual function.

A 529 plan is an education savings plan operated by a state or educational institution designed to help families set aside funds for future college costs.

Some urologists have started experimenting with social media due to patient demand. Others are taking a wait-and-see approach while weighing the benefits and possible drawbacks.

As physicians, hospitals, insurance companies, and other organizations grapple with this new entity, it appears there are more questions than answers.

Urologists say spending time with family helps them deal with the stress of practicing medicine.

Taking a brief patient service quiz can help you determine what you're doing right and what areas could use improvement.

Determined to defend their profession and their practices, some 180 urologists from 39 states across the nation came to Washington in late March for the 2011 Joint Advocacy Conference, sponsored by the AUA and the American Association of Clinical Urologists.

Continuous dosing of sunitinib (Sutent) proved no better than the conventional 4/2 regimen in patients with metastatic renal cell carcinoma.

Every ethnic group is represented in Washington, from Vietnamese to Soul, Peruvian to Belgian in all parts of the city. There are far too many restaurants to mention each one, but the following offer a sample of what is available in a few of the sections near downtown and Capitol Hill and recommended by the visitor's bureau. Note that all phone numbers use the 202 area code.

Urologists who came to Washington in March to let Congress know their concerns about key regulatory issues had a big target in mind-killing the Independent Payment Advisory Board, created by the new health care reform law as a way to reduce Medicare costs.

Intermittent androgen suppression is as effective as continuous androgen deprivation, according to a non-inferiority study of men with a rising PSA following definitive primary therapy for prostate cancer.

In this article, you'll find information about products and services from manufacturers that are exhibiting at the American Urological Association annual meeting in Washington. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.

Urology drugs and devices that are in the pipeline from Astellas Pharma, Inc., Teva Pharmaceutical Industries Ltd., Medivation, Inc., Nymox Pharmaceutical Corp., and TARIS Biomedical.

A gene signature comprising four different single-nucleotide polymorphisms associated with response to platinum-based therapy in patients with urothelial carcinoma has been identified by Irish and U.S. researchers.

Researchers have identified a four-gene signature that may significantly advance the current clinical ability to differentiate indolent from aggressive prostate cancer in the mouse model and in human tissue samples.

Men who regularly use nonsteroidal anti-inflammatory drugs (NSAIDs) have an increased risk of erectile dysfunction.

Surgeons who care for men with Peyronie's disease must be familiar with grafting procedures in order to offer the full spectrum of options.

Results from in vitro and preclinical models provide proof of concept that SPINK1 (serine peptidase inhibitor, Kazal type 1) may be a viable therapeutic target for a subset of prostate cancer patients with an aggressive subtype of disease.

Evidence of MSH5 mismatch repair gene deficiencies in nonobstructive azoospermic men suggests that these men should receive genetic counseling if they plan to have children via intracytoplasmic sperm injection.

Sperm retrieval rates for microdissection testicular sperm extraction remained constant between 1997 and 2009, except for an increase in SRRs in patients with Sertoli cell only.

In adults receiving radiotherapy for cancer, a relatively small proportion of second cancers are related to the treatment itself, suggesting that most are due to other factors, such as lifestyle or genetics, according to a recent study.

Mutations of a gene called KRAS may drive metastatic prostate cancer, say researchers from the University of Michigan, Ann Arbor.

Exposure to androgen deprivation therapy is associated with worse physical well being in patients with prostate cancer, according to a recent study.

A new PSA test appears to more accurately identify men with prostate cancer, particularly the aggressive form of the disease, and substantially reduce false positives compared with the two currently available tests, say researchers from Northwestern University, Chicago.

The American Board of Medical Specialties (ABMS) has announced the creation of physician certification in female pelvic medicine and reconstructive surgery, which will be administered by the American Board of Obstetrics and Gynecology (ABOG) and the American Board of Urology (ABU).

Two novel genetic markers appear to be associated with earlier time to prostate cancer diagnosis among African-American men, according to research presented at the American Association for Cancer Research annual meeting in Orlando, FL.

Uroplasty, Inc., has announced that several payers will cover posterior tibial nerve stimulation (PTNS) using the company's Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms.

Rather than looking for tumors directly in patients with prostate cancer, analyzing non-tumor tissue may be an effective option as well, according to a recent study.

Genetic factors explain half of a person?s susceptibility to urinary incontinence, Swedish researchers report.